Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central nervous technique, conolidine modulates alternate molecular targets. A Science Innovations review identified that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://thebookmarknight.com/story20810052/helping-the-others-realize-the-advantages-of-alternative-natural-pain-relief-to-replace-traditional-painkillers